|
Preferred Name |
Bicalutamide
|
|
Definition |
A synthetic, nonsteroidal antiandrogen. Bicalutamide competitively binds to cytosolic androgen receptors in target tissues, thereby inhibiting the receptor binding of androgens. This agent does not bind to most mutated forms of androgen receptors. (NCI04)/NCI-GLOSS Definition: An anticancer drug that belongs to the family of drugs called antiandrogens.
|
|
Synonyms & Abbreviations |
(+/-)-N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide
4'-Cyano-alpha,alpha,alpha-trifuloro-3-[(p-fluorophenyl)sulfonyl]-2-methyl-m-lactotoluidide
4-Cyano-3-trifluoromethyl-N-(3-p-fluorophenylsulfonyl-2-hydroxy-2-methylpropionyl)aniline
Bicalutamide
BICALUTAMIDE
bicalutamide
Casodex
Cosudex
ICI 176,334
ICI 176334
N-[4-Cyano-3-(trifluoromethyl)phenyl]3-3[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methyl-propanamide
|
|
ReferenceCode |
NCI Thesaurus Code:C1599
|
|
ReferenceURL |
https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C1599
|
|
PMID |
NA
|